New microfluidic device improves the separation of tumor cells and clusters from malignant effusions

Researchers have unveiled a microfluidic device that significantly improves the separation of tumor cells and clusters from malignant effusions.

Convincing overall performance – Formycon reports preliminary results for the financial year 2023 and exceeds forecast – Biotech Investments

EQS-News: Formycon AG / Key word(s): Preliminary Results/Forecast Convincing overall performance – Formycon reports preliminary results for the financial year 2023 and exceeds forecast 12.04.2024

April 13, 2024

Prescription for resilience: Health care needs financial sector-inspired regulation

In the early days after it was hit by a cyberattack on Feb. 21, Change Healthcare, one of the country’s largest claims and prescription processors,

March 14, 2024

Novel PET radiotracer shows high sensitivity, specificity in diagnosing coronary artery disease in obese patients

A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese patients with a higher sensitivity and specificity compared to 99mTc-SPECT myocardial

June 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.